North America Radiotherapy Monitoring Devices Market Outlook

the north america radiotherapy monitoring devices market is expected to reach an estimated value of $xx million in 2018 and is projected to register a cagr of xx.x% during the forecast period 2018 to 2032. the market is likely to be held back by the automated radiotherapy market which is considered to be the predominant technology in the radiotherapy segment. this might become a significant restraining factor in the market. radiotherapy monitoring devices comprises of dosimeters, imagers, and other devices that help measure radiation exposure. technological advancements in radiotherapy delivery devices, such as best angle beam, and advanced treatment delivery systems like intensity modulated radiation therapy (imrt), have enabled accurate and precise delivery of high doses of radiation which increases the reliability of radiotherapy treatment. this is projected to fuel the growth of the radiotherapy monitoring devices market. the north america radiotherapy monitoring devices market is segmented on the basis of type into dosimetry equipment and imaging & guidance systems. the dosimetry equipment segment holds the largest market share and is rapidly growing due to increasing number of cancer cases and rising patients’ propensity to opt for radiotherapy treatment. the imaging & guidance systems segment is also expected to witness notable growth, as recent advancements in medical imaging technology reduce the exposure time, enhance the image quality and accuracy of radiation delivery. in north america, the u.s. radiotherapy monitoring devices market is expected to continue its dominance over the forecast period. factors such as increasing demand for radiotherapy treatment and adoption of modern imaging & guidance systems are driving the growth of the radiotherapy monitoring devices market in the u.s. canada and mexico are expected to remain the second and third largest markets throughout the forecast period due to increased investment in the healthcare sector. the major players in the north america radiotherapy monitoring devices market are gamma medica inc., accuray inc., philips healthcare, varian medical systems, and elekta ab. factors such as huge investments for research & development, strategic acquisitions and partnerships are few strategies adopted by the key players in the market. increased focus on enhancing radiotherapy services is expected to attract more players in the north america radiotherapy monitoring devices market over the forecast period. growing recognition of radiotherapy treatments, increasing research activities, and continual technological advancements are expected to open up new opportunities for the radiotherapy monitoring devices market.